Clinical Trial Update: A Study of Single Dose of ABT-333 in Healthy Male Adults [Phase 1]

View source ↗

Summary

Phase 1 single-dose study of ABT-333 in healthy male adults completed; assesses safety and pharmacokinetics in the context of hepatitis C infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-333 (ABT-333)

Snippet

Sponsor: Abbott | Conditions: HCV Infections | Phase 1 | Status: COMPLETED